REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Labvy Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Miscellaneous Store Retailers | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Laboratorio Clinico Labvy Sas Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Clinico Labvy Sas is a company based in Colombia, with its head office in Montelibano. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on April 02, 2013. The latest financial highlights indicate a net sales revenue increase of 31.3% in 2023. Its’ total assets recorded a growth of 2.33%. The net profit margin of Laboratorio Clinico Labvy Sas increased by 18.5% in 2023.

Headquarters
Carrera 9 No. 15 - 20 Barrio Tierra Grata
Montelibano; Cordoba;

Contact Details: Purchase the Laboratorio Clinico Labvy Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Laboratorio Clinico Labvy Sas report to view the information.
Incorporation Date:
April 02, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Clinico Labvy Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.3%
Total operating revenue
31.3%
Operating profit (EBIT)
114.62%
Net Profit (Loss) for the Period
192.53%
Total assets
2.33%
Total equity
-29.03%
Operating Profit Margin (ROS)
16.57%
Net Profit Margin
18.5%
Return on Equity (ROE)
53.52%
Debt to Equity Ratio
33.19%
Quick Ratio
-0.91%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?